Sandra Leung and Curt Oltmans were selected in the LSIPR 50 2016 publication for their influence on the life sciences industry. Leung and Curt Oltmans were featured in the legal section, as LSIPR reports.
Name: Sandra Leung
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Sandra Leung, Curt Oltmans, Bristol-Myers Squibb, pharmaceutical industry, patent, trademark, copyright, Novo Nordisk, IP law, insulin, HEPtune, legal,